Anthony Rothschild, MD
Psychiatry · Worcester, MANPI 1841278488
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,693 of the $34,397 with a category attached, or 89.2%. Sage Therapeutics, LLC accounts for 64.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $15,951 and has fallen 99.1% since, to $136 in 2025. Among psychiatry clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $648.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$22K
- Johnson & Johnson$10K
- Daiichi Sankyo Inc.$2K
- Boehringer Ingelheim$295
- Axsome Therapeutics, Inc.$166
- Biogen$58
- plus $31 from 1 others
Across 116 payments — averaging $6942.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$639K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$108K
- AbbVie$50K
- Takeda Pharmaceuticals U.S.A., Inc.$9K
What the payments were for
- Consulting fees$30,69389%
- Travel & lodging$2,8048%
- Food & beverage$9013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 27 | $22,138 |
| Johnson & Johnson | 18 | $9,968 |
| Daiichi Sankyo Inc. | 1 | $1,740 |
| Boehringer Ingelheim | 3 | $295 |
| Axsome Therapeutics, Inc. | 2 | $166 |
| Biogen | 1 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,397 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 30 | $616 |
| Trazodone Hcl | 36 | $457 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $350 |
| Olanzapine | 30 | $270 |
| Sertraline Hcl | 17 | $241 |
| Bupropion Hcl | 16 | $190 |
| Lorazepam | 53 | $159 |
| Aripiprazole | 18 | $153 |
| Hydroxyzine Hcl | 20 | $128 |
| Buspirone Hcl | 14 | $128 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Worcester
- Amjad BahnassiWorcester$352K
- Mohamed OchWorcester$45K
- Mark SchlickmanWorcester$41K
- Theresa CerulliNorth Andover$724K
- Andrew AldridgeMedford$407K
- Ximena Sanchez-SamperBoston$258K
- Robert AlexanderBelmont$170K
- George PapakostasBoston$170K
- Xiangyang LiMilford$166K
- Ernesto ZilberbergNorth Andover$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.